Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer

Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer

AbstractAim: This comprehensive review aims to explore the potential applications of Gastrin-releasing peptide receptor (GRPR) in the diagnosis and treatment of prostate cancer. Additionally, the study investigates the role of GRPR in prognostic assessment for individuals afflicted with prostate can...

Full description

Bibliographic Details
Main Authors:	Honghu Zhang, Lin Qi, Yi Cai, Xiaomei Gao
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Annals of Medicine
Subjects:	PET Gastrin-releasing peptide receptor(GRPR) prostate cancer radiomics radionuclide-targeted therapy diagnosis
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2024.2320301

Similar Items

Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist
by: Michael Hofstetter, et al.
Published: (2020-11-01)

Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
by: Ayman Abouzayed, et al.
Published: (2020-10-01)

GRPR-targeting radiotheranostics for breast cancer management
by: Alice D’Onofrio, et al.
Published: (2023-11-01)

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches
by: Marjolein Verhoeven, et al.
Published: (2023-08-01)

Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?
by: Pinuccia Faviana, et al.
Published: (2021-03-01)

Stability Evaluation and Stabilization of a Gastrin-Releasing Peptide Receptor (GRPR) Targeting Imaging Pharmaceutical
by: Arijit Ghosh, et al.
Published: (2019-08-01)

Inhibition of Gastrin-Releasing Peptide Attenuates Phosphate-Induced Vascular Calcification
by: Hyun-Joo Park, et al.
Published: (2020-03-01)

Interaction between substance P and gastrin-releasing peptide on thyrotropin secretion by rat pituitary in vitro
by: E.G. Moura, et al.
Published: (1999-09-01)

68Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study
by: Yilin Li, et al.
Published: (2025-01-01)

GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics
by: Karim Obeid, et al.
Published: (2024-04-01)

Gastrin-releasing peptide receptor expression in gastrointestinal stromal tumours
by: M. Berndsen, et al.
Published: (2024-12-01)

Improvement of autism spectrum disorder symptoms in three children by using gastrin‐releasing peptide
by: Michele Michelin Becker, et al.
Published: (2016-05-01)

Localization of <sup>99m</sup>Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses
by: Aikaterini Kaloudi, et al.
Published: (2019-03-01)

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9
by: Silvano Gnesin, et al.
Published: (2018-12-01)

Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics
by: Ayman Abouzayed, et al.
Published: (2023-07-01)

Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer
by: Cui DT, et al.
Published: (2017-09-01)

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
by: Ayman Abouzayed, et al.
Published: (2019-07-01)

Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer
by: Andreas Rinscheid, et al.
Published: (2024-04-01)

Human gastrin- releasing peptide receptor expression in women with uterine cervix cancer
by: Charles A. Kunos, et al.
Published: (2023-01-01)

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
by: Fanny Lundmark, et al.
Published: (2020-07-01)

Function of gastrin-releasing peptide receptors in ocular itch transmission in the mouse trigeminal sensory system
by: Keiko Takanami, et al.
Published: (2023-11-01)

Plasma progastrin‐releasing peptide level shows different predictive profiles for treatment response by androgen receptor axis‐targeted agents in patients with metastatic castration‐resistant prostate cancer
by: Masahiro Yashi, et al.
Published: (2023-03-01)

Gastrin-releasing peptide receptor expression in non-cancerous bronchial epithelia is associated with lung cancer: a case-control study
by: Egloff Ann Marie, et al.
Published: (2012-02-01)

New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer
by: Xin Li, et al.
Published: (2020-12-01)

The majority of dorsal spinal cord gastrin releasing peptide is synthesized locally whereas neuromedin B is highly expressed in pain- and itch-sensing somatosensory neurons
by: Fleming Michael S, et al.
Published: (2012-07-01)

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice
by: Aikaterini Kaloudi, et al.
Published: (2017-11-01)

Exploring the application value of pro‐gastrin‐releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma
by: Qiang Miao, et al.
Published: (2023-10-01)

Oxytocin Elicits Itch Scratching Behavior via Spinal GRP/GRPR System
by: Jing Guo, et al.
Published: (2020-09-01)

The effects of a growth hormone-releasing hormone antagonist and a gastrin-releasing peptide antagonist on intimal hyperplasia of the carotid artery after balloon injury in a diabetic rat model☆
by: John C. Moscona, et al.
Published: (2017-07-01)

Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer
by: Christina Baun, et al.
Published: (2020-12-01)

Synaptic circuits involving gastrin-releasing peptide receptor-expressing neurons in the dorsal horn of the mouse spinal cord
by: Raphaëlle Quillet, et al.
Published: (2023-12-01)

Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer
by: Maryana Handula, et al.
Published: (2022-01-01)

Bioorthogonal Chemistry Approach for the Theranostics of GRPR-Expressing Cancers
by: Alice D’Onofrio, et al.
Published: (2022-11-01)

Preclinical Evaluation of <sup>99m</sup>Tc-Labeled GRPR Antagonists maSSS/SES-PEG<sub>2</sub>-RM26 for Imaging of Prostate Cancer
by: Ayman Abouzayed, et al.
Published: (2021-01-01)

Chemogenetic activation of central gastrin‐releasing peptide‐expressing neurons elicits itch‐related scratching behavior in male and female mice
by: Norikazu Kiguchi, et al.
Published: (2021-05-01)

Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer
by: Truc T. Huynh, et al.
Published: (2022-06-01)

Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology
by: Panagiotis Kanellopoulos, et al.
Published: (2024-02-01)

Downregulation of the NPY-Y1R system in Grpr neurons results in mechanical and chemical hyperknesis in chronic itch
by: Danqing Dai, et al.
Published: (2025-03-01)

Imaging Properties and Tumor Targeting of <sup>68</sup>Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients
by: Leonhard Gruber, et al.
Published: (2022-11-01)

Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
by: Thomas Franz Fassbender, et al.
Published: (2020-06-01)